When it comes to treating and hopefully beating cancer, early action matters. That’s why prevention-focused clinical trials play a critical role in public health and medical research.
Unlike treatment-focused clinical trials, which test therapies after a disease is diagnosed, prevention trials aim to stop disease before it starts or comes back.
For high-risk populations, including people exposed to asbestos, prevention trials can offer powerful insight into reducing the risk of developing mesothelioma and other asbestos-related diseases.
What Are Prevention Clinical Trials?
Prevention trials are clinical studies designed to find ways to prevent disease or delay its onset. These trials evaluate interventions such as:
- Medications (chemoprevention)
- Vaccines
- Lifestyle changes
- Dietary supplements
- Environmental or workplace strategies
Prevention trials are typically divided into two categories:
- Primary Prevention Trials – For people who have never had the disease but may be at risk
- Secondary Prevention Trials – For people who’ve had the disease, treated it, and want to prevent it from returning
Why Are Prevention Clinical Trials Important?
These trials aim to answer big picture questions like:
- Can this medication lower the risk of cancer in high-risk individuals?
- Does a vaccine offer protection against cancer-causing viruses?
- Will quitting smoking or changing diet reduce recurrence risk?
- What interventions can protect workers exposed to environmental hazards?
In short, prevention trials are about stopping cancer before it takes hold, rather than waiting to treat it after diagnosis.
Prevention Clinical Trials for Mesothelioma: What We Know
Mesothelioma is an aggressive cancer caused entirely by exposure to asbestos. Because there is no known cure and treatments have limited success, prevention is especially critical in this disease.
The best way to prevent mesothelioma is to avoid exposure to asbestos, which is a toxic mineral once used in construction, shipbuilding, and manufacturing. The issue is asbestos was practically everywhere during the second half of the 20th century – in every building, automobile and more.
Asbestos fibers, which are what cause mesothelioma, are also small and invisible to the human eye. Therefore, no one could know whether they were exposed or not.
The hope is scientists could discover a way to prevent mesothelioma after someone is exposed to asbestos. This type of cancer takes 20-50 years to form after asbestos fibers enter a person’s body. This means there’s a long period of time between exposure and cells turning malignant.
Can science evolve to a place where people can be tested for exposure and then receive a treatment that stops cells from mutating into cancer?
While treatment trials are common in mesothelioma, true prevention trials are rare but not nonexistent.
Examples of Mesothelioma-Related Prevention Trials
Here are several examples of prevention-focused efforts involving mesothelioma risk.
Chemoprevention Studies With Antioxidants
- What they tested: Agents like vitamin A (retinoids) or N-acetylcysteine were explored in asbestos-exposed workers to see if they could reduce cellular damage and cancer risk.
- Outcome: These trials did not show clear prevention benefits, but they paved the way for further research into antioxidant pathways.
Mesothelioma Vaccine Development (Experimental/Preventive Focus)
- What’s being studied: Some experimental vaccines aim to stimulate immune response in high-risk individuals, such as former asbestos workers, even before cancer develops. This can help the immune system start fighting the disease in early stages.
- Status: It’s mostly in early-stage research or preclinical phases, but the concept holds promise for future prevention strategies.
Occupational Safety and Regulatory Studies
- While not traditional “clinical trials,” numerous studies have evaluated engineering controls, respirator use, and decontamination protocols to prevent asbestos exposure among workers. These form a large part of prevention efforts tied to mesothelioma.
Surveillance-Based Prevention Programs
- Example: In places like Australia and the United Kingdom, long-term asbestos registries and screening programs monitor high-risk populations (like shipyard workers) to detect early lung changes. Some trials have tested regular computed tomography (CT) scans to catch early mesothelioma or lung cancer in exposed populations.
Who Can Join a Prevention Clinical Trial for Mesothelioma?
Eligibility depends on the study’s focus. Common criteria include:
- A history of asbestos exposure (miners, shipyard workers and military personnel)
- Smoking history (increases the risk of lung cancer)
- Family history of cancer (does not apply to mesothelioma)
- Age and general health status
Some trials are only open to people with no cancer diagnosis, while others involve cancer survivors seeking to prevent recurrence.
Final Thoughts on Prevention Clinical Trials: Prevention Is Power
When it comes to diseases like mesothelioma, where treatment options are limited and survival prognosis is often discouraging, prevention offers the greatest opportunity to save lives. The issue is many people are unaware when they are exposed to asbestos, which is the only cause of mesothelioma. Therefore, they cannot prevent it themselves.
Government regulations, such as the recent ban of asbestos in the United States, can help prevent the use of asbestos in the future. However, prevention clinical trials offer hope for people who are still exposed and develop the disease despite rules against asbestos’ use.
Although there are few mesothelioma-specific prevention trials today, the importance of reducing asbestos exposure and monitoring high-risk individuals cannot be overstated. There is a long window of time between asbestos exposure and the development of mesothelioma. This means there’s a lengthy amount of time to detect if someone is at risk and develop a treatment to prevent cells from mutating into cancer.
As mesothelioma research and cancer research in general advances, the hope is that more innovative prevention strategies – including immune-based therapies, vaccines and environmental interventions – will offer new protection for those most at risk.
If you believe you’re at risk for mesothelioma or have a history of asbestos exposure, talk to your doctor about screening options or visit https://clinicaltrials.gov/.
Read More From Mesothelioma Guide’s Clinical Trials Blog Series
Here is a list of all published blogs in the series on mesothelioma clinical trials:
Sources & Author
